Supernus Pharmaceuticals | SUPN - صافي الدخل





صافي الدخل تغيير تاريخ
Abbott USD 928M 149M 2026-06
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -157.11M 94.49M 2026-03
Cara Therapeutics USD -5.53M 621K 2025-09
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Eisai JPY -3.25B 20.43B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Novo Nordisk DKK 26.89B 388M 2025-12
Pacira USD 2.92M 1.28M 2026-03
Perrigo USD -398.6M 1.02B 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
United Therapeutics USD 274.9M 89.4M 2026-03
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03